Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury

Biochemical and Biophysical Research Communications

Volumn 472, Issue 2, 2016, Pages 392-398

  Kanwal, Abhinav ^a,c   Nizami, Hina L ^a   Mallapudi, Surekha ^b   Putcha, Uday Kumar ^b   Mohan, G Krishna ^c   Banerjee, Sanjay K ^a,d  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^d TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

Author keywords

Ischemia reperfusion injury; Oxidative stress; Phlorizin; Preconditioning; SGLT1

Indexed keywords

CASPASE 3; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER 1; SLC5A1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TUNEL ASSAY; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; HEART INFARCTION PREVENTION; IN VITRO STUDY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; IN VITRO TECHNIQUES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-GLUCOSE TRANSPORTER 1; TREATMENT OUTCOME;

EID: 84959885090     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.02.016     Document Type: Article

References (19)

1. Jianxun Liu, Hua Zhu, Yongqiu Zheng, Zhaobin Xu, Lei Li, Tao Tan, Ki Ho Park, and et al. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury J. Mol. Cell. Cardiol. 80 2015 10 19
2. Shyamal K. Goswami, Nilanjana Maulik, and Dipak K. Das Ischemia-reperfusion and cardioprotection: A delicate balance between reactive oxygen species generation and redox homeostasis Ann. Med. 39 4 2007 275 289
3. Andrew J. Murray, Craig A. Lygate, Mark A. Cole, Carolyn A. Carr, George K. Radda, Stefan Neubauer, and Kieran Clarke Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart Cardiovasc. Res. 71 1 2006 149 157
4. Charles E. Murry, Robert B. Jennings, and Keith A. Reimer Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium Circulation 74 5 1986 1124 1136
5. Haimei Sun, Tao Guo, Liu Liu, Zhuo Yu, Wangbing Xu, Wenhui Chen, Lijuan Shen, Jiaping Wang, and Xingkui Dou Ischemic postconditioning inhibits apoptosis after acute myocardial infarction in pigs In Heart Surg. Forum 13 5 2010 E305 E310
6. Lele Ji, Xing Zhang, Wenchong Liu, Qichao Huang, Weidong Yang, Feng Fu, Heng Ma, and et al. AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury PloS one 8 7 2013 e69910
7. Supriya Subramanian, Petra Glitz, Helmut Kipp, Rolf KH. Kinne, and Francisco Castaneda Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1 J. Cell. Biochem. 106 3 2009 444 452
8. Sanjay K. Banerjee, David W. Wang, Rodrigo Alzamora, Xueyin N. Huang, Núria M. Pastor-Soler, Kenneth R. Hallows, Kenneth R. McGaffin, and Ferhaan Ahmad SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy J. Mol. Cell. Cardiol. 49 4 2010 683 692
9. Sanjay K. Banerjee, Kenneth R. McGaffin, Núria M. Pastor-Soler, and Ferhaan Ahmad SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states Cardiovasc. Res. 2009 cvp190
10. Abhinav Kanwal, Shailendra Pratap Singh, Paramjit Grover, and Sanjay Kumar Banerjee Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2 Anal. Biochem. 429 1 2012 70 75
11. Tarak Nath Khatua, Amit K. Dinda, Uday K. Putcha, and Sanjay K. Banerjee Diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via eNOS-Nrf2-Tfam pathway in rats Biochem. Biophys. Rep. 5 2016 77 88
12. Pankaj K. Bagul, Nancy Deepthi, Razia Sultana, and Sanjay K. Banerjee Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3 J. Nutr. Biochem 26 11 2015 1298 1307
13. Yusuke Kashiwagi, Tomohisa Nagoshi, Takuya Yoshino, Toshikazu D. Tanaka, Keiichi Ito, Tohru Harada, Hiroyuki Takahashi, Masahiro Ikegami, Ryuko Anzawa, and Michihiro Yoshimura Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemia-reperfusion injury in mice PloS One 10 6 2015 e0130605
14. Sanjay K. Banerjee, Ravi Ramani, Samir Saba, Jennifer Rager, Rong Tian, Michael A. Mathier, and Ferhaan Ahmad A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia Biochem. Biophys. Res. Comm. 360 2 2007 381 387
15. Yasuhiro Nishino, Tetsuji Miura, Takayuki Miki, Jun Sakamoto, Yuichi Nakamura, Yoshihiro Ikeda, Hironori Kobayashi, and Kazuaki Shimamoto Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection Cardiovasc. Res. 61 3 2004 610 619
16. Katharine H. Wrighton Signalling: Survival of the sweetest Nat. Rev. Cancer. 8 7 2008 484 485
17. Zhang Weihua, Rachel Tsan, Wei-Chien Huang, Qiuyu Wu, Chao-Hua Chi, Isaiah J. Fidler, and Mien-Chie Hung Survival of cancer cells is maintained by EGFR independent of its kinase activity Cancer Cell 13 5 2008 385 393
18. Lubing Zhou, Ellen V. Cryan, Michael R. D'Andrea, Stanley Belkowski, Bruce R. Conway, and Keith T. Demarest Human cardiomyocytes express high level of Na+/glucose co transporter 1 (SGLT1) J. Cell. Biochem. 90 2 2003 339 346
19. Magali Balteau, Nicolas Tajeddine, Meester Carole de, Audrey Ginion, Christine Des Rosiers, Nathan R. Brady, Caroline Sommereyns, and et al. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1 Cardiovasc. Res. 92 2 2011 237 246